Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia-Reference-Cited by-同舟云学术

Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia

Published:2016-06-25 Issue:8 Volume:91 Page:800-805
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Badar Talha¹,Handisides Damian R.²,Benito Juliana M.¹,Richie Mary Ann¹,Borthakur Gautam¹,Jabbour Elias¹,Harutyunyan Karine¹,Konoplev Sergej³,Faderl Stefan¹,Kroll Stew²,Andreeff Michael¹⁴,Pearce Tillman²,Kantarjian Hagop M.¹,Cortes Jorge E.¹,Thomas Deborah A.¹,Konopleva Marina¹⁴

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Threshold Pharmaceuticals; South San Francisco California

3. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Stem Cell Transplantation and Cellular Therapy; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

Threshold Pharmaceuticals

Merck KGaA, Darmstadt, Germany

NIH/NCI

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24415/fullpdf

Reference33 articles.

1. Targeting hypoxia in cancer therapy;Wilson;Nat Rev Cancer,2011

2. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics;Semenza;Oncogene,2010

3. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases;Zhong;Cancer Res,1999

4. The influence of microenvironmental factors during cancer therapy;Durand;In Vivo,1994

5. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy;Gray;Br J Radiol,1953

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the bone marrow niche, moving towards leukemia eradication;Frontiers in Hematology;2024-07-22

2. HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies;Genes & Diseases;2024-01

3. Assessment of hypoxia-targeting therapy for gastrointestinal lymphoma in dogs: Preclinical test using murine models;Research in Veterinary Science;2023-01

4. Predicting response to combination evofosfamide and immunotherapy under hypoxic conditions in murine models of colon cancer;MATH BIOSCI ENG;2023

5. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia;International Journal of Molecular Sciences;2022-12-29